GoodRx Holdings GDRX
$ 4.53
0.78%
Quarterly report 2024-Q3
added 11-07-2024
GoodRx Holdings Balance Sheet 2011-2024 | GDRX
Annual Balance Sheet GoodRx Holdings
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-18.4 M | -101 M | -279 M | -302 M | 645 M | 688 M | - | - | - | - | - | - | - |
Long Term Debt |
648 M | 652 M | 656 M | 660 M | 664 M | 717 M | - | - | - | - | - | - | - |
Long Term Debt Current |
6.18 M | 4.07 M | 5.85 M | 4.54 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 699 M | 1.44 B | 1.46 B | - | - | - | - | - | - | - |
Total Current Liabilities |
123 M | 76.3 M | 81.1 M | 59.6 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
827 M | 790 M | 776 M | 759 M | 1.47 B | 1.48 B | - | - | - | - | - | - | - |
Deferred Revenue |
7.1 M | 7.88 M | 6.87 M | 6.85 M | 3.45 M | 258 K | - | - | - | - | - | - | - |
Retained Earnings |
-1.46 B | -1.45 B | -1.42 B | -1.39 B | -1.1 B | -1.16 B | - | - | - | - | - | - | - |
Total Assets |
1.59 B | 1.6 B | 1.61 B | 1.47 B | 387 M | 315 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
672 M | 757 M | 941 M | 969 M | 26 M | - | - | - | - | - | - | - | - |
Book Value |
762 M | 815 M | 832 M | 711 M | -1.09 B | -1.16 B | - | - | - | - | - | - | - |
Total Shareholders Equity |
762 M | 815 M | 832 M | 711 M | -1.09 B | -1.16 B | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet GoodRx Holdings
2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
488 M | 646 M | 649 M | 650 M | 651 M | 652 M | - | 654 M | 655 M | 656 M | 657 M | 658 M | 659 M | 660 M | 660 M | 660 M | 660 M | 664 M | 664 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
658 M | 806 M | 827 M | 797 M | 784 M | 790 M | - | 774 M | 752 M | 776 M | 768 M | 763 M | 762 M | 759 M | 759 M | 759 M | 759 M | 737 M | 737 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
6.33 M | 5.99 M | 8.34 M | 9.66 M | 10.8 M | 7.88 M | - | 11.5 M | 10.3 M | 6.87 M | 8.21 M | 8.9 M | 8.8 M | 6.85 M | 6.85 M | 6.85 M | 6.85 M | 3.45 M | 3.45 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.45 B | -1.45 B | -1.43 B | -1.39 B | -1.45 B | -1.45 B | - | -1.4 B | -1.4 B | -1.42 B | -1.38 B | -1.36 B | -1.39 B | -1.39 B | -1.39 B | -1.39 B | -1.39 B | -1.1 B | -1.1 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
1.35 B | 1.48 B | 1.71 B | 1.69 B | 1.61 B | 1.6 B | - | 1.59 B | 1.54 B | 1.61 B | 1.61 B | 1.59 B | 1.51 B | 1.47 B | 1.47 B | 1.47 B | 1.47 B | 387 M | 387 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
424 M | 525 M | 795 M | 762 M | 761 M | 757 M | - | 731 M | 845 M | 941 M | 912 M | 895 M | 990 M | 969 M | 969 M | 969 M | 969 M | 26 M | 26 M | - | - | 34.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
696 M | 669 M | 881 M | 895 M | 827 M | 815 M | - | 818 M | 787 M | 832 M | 846 M | 824 M | 749 M | 711 M | 711 M | 711 M | 711 M | -351 M | -351 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
696 M | 669 M | 881 M | 895 M | 827 M | 815 M | 788 M | 818 M | 787 M | 832 M | 846 M | 824 M | 749 M | 711 M | 711 M | 711 M | 711 M | -1.09 B | -1.09 B | -1.13 B | -1.15 B | -1.16 B | - | - | - | -31.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency